These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 29992590

  • 1. One-year follow-up of the prospective registry of patients using the wearable defibrillator (WEARIT-II Registry).
    Kutyifa V, Moss AJ, Klein HU, McNitt S, Zareba W, Goldenberg I.
    Pacing Clin Electrophysiol; 2018 Oct; 41(10):1307-1313. PubMed ID: 29992590
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.
    Daimee UA, Vermilye K, Moss AJ, Goldenberg I, Klein HU, McNitt S, Zareba W, Kutyifa V.
    Heart Rhythm; 2018 Sep; 15(9):1379-1386. PubMed ID: 29678779
    [Abstract] [Full Text] [Related]

  • 4. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator.
    Goldenberg I, Erath JW, Russo AM, Burch AE, Assmus B, Bonderman D, McNitt S, Kutyifa V.
    Heart Rhythm; 2021 Mar; 18(3):404-410. PubMed ID: 33248269
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry.
    Veltmann C, Winter S, Duncker D, Jungbauer CG, Wäßnig NK, Geller JC, Erath JW, Goeing O, Perings C, Ulbrich M, Roser M, Husser D, Gansera LS, Soezener K, Malur FM, Block M, Fetsch T, Kutyifa V, Klein HU.
    Clin Res Cardiol; 2021 Jan; 110(1):102-113. PubMed ID: 32377784
    [Abstract] [Full Text] [Related]

  • 7. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S, Rosenkaimer SL, Hohneck A, Lang S, El-Battrawy I, Rudic B, Tülümen E, Stach K, Kuschyk J, Akin I, Borggrefe M.
    BMC Cardiovasc Disord; 2018 Mar 15; 18(1):52. PubMed ID: 29544442
    [Abstract] [Full Text] [Related]

  • 8. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
    Ellenbogen KA, Koneru JN, Sharma PS, Deshpande S, Wan C, Szymkiewicz SJ.
    JACC Clin Electrophysiol; 2017 Mar 15; 3(3):243-250. PubMed ID: 29759518
    [Abstract] [Full Text] [Related]

  • 9. Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD.
    Kaspar G, Sanam K, Gholkar G, Bianco NR, Szymkiewicz S, Shah D.
    Int J Cardiol; 2018 Dec 01; 272():179-184. PubMed ID: 30121177
    [Abstract] [Full Text] [Related]

  • 10. The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients.
    Erath JW, Vamos M, Sirat AS, Hohnloser SH.
    Clin Res Cardiol; 2017 Apr 01; 106(4):300-306. PubMed ID: 27888304
    [Abstract] [Full Text] [Related]

  • 11. Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study.
    Garcia R, Combes N, Defaye P, Narayanan K, Guedon-Moreau L, Boveda S, Blangy H, Bouet J, Briand F, Chevalier P, Cottin Y, Da Costa A, Degand B, Deharo JC, Eschalier R, Extramiana F, Goralski M, Guy-Moyat B, Guyomar Y, Hermida JS, Jourda F, Lellouche N, Mahfoud M, Manenti V, Mansourati J, Martin A, Pasquié JL, Ritter P, Rollin A, Tibi T, Yalioua A, Gras D, Sadoul N, Piot O, Leclercq C, Marijon E.
    Europace; 2021 Jan 27; 23(1):73-81. PubMed ID: 33257972
    [Abstract] [Full Text] [Related]

  • 12. Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland.
    Kovacs B, Reek S, Saguner AM, Krasniqi N, Eriksson U, Duru F.
    Swiss Med Wkly; 2019 Nov 04; 149():w20136. PubMed ID: 31707723
    [Abstract] [Full Text] [Related]

  • 13. The Wearable Cardioverter-Defibrillator: Experience in 153 Patients and a Long-Term Follow-Up.
    Rosenkaimer SL, El-Battrawy I, Dreher TC, Gerhards S, Röger S, Kuschyk J, Borggrefe M, Akin I.
    J Clin Med; 2020 Mar 24; 9(3):. PubMed ID: 32214048
    [Abstract] [Full Text] [Related]

  • 14. Study of the wearable cardioverter defibrillator in advanced heart-failure patients (SWIFT).
    Barsheshet A, Kutyifa V, Vamvouris T, Moss AJ, Biton Y, Chen L, Storozynsky E, Wan C, Szymkiewicz SJ, Goldenberg I.
    J Cardiovasc Electrophysiol; 2017 Jul 24; 28(7):778-784. PubMed ID: 28429542
    [Abstract] [Full Text] [Related]

  • 15. Clinical experience with wearable cardioverter defibrillators at a tertiary electrophysiology program.
    Bossory L, Schubert S, Afzal MR, Weiss R, Tyler J, Kalbfleisch S, Augostini R, Hummel J, Okabe T, Daoud EG, Houmsse M.
    Pacing Clin Electrophysiol; 2018 Nov 24; 41(11):1491-1494. PubMed ID: 30191582
    [Abstract] [Full Text] [Related]

  • 16. Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator.
    Zishiri ET, Williams S, Cronin EM, Blackstone EH, Ellis SG, Roselli EE, Smedira NG, Gillinov AM, Glad JA, Tchou PJ, Szymkiewicz SJ, Chung MK.
    Circ Arrhythm Electrophysiol; 2013 Feb 24; 6(1):117-28. PubMed ID: 23275233
    [Abstract] [Full Text] [Related]

  • 17. Prior history of atrial fibrillation and arrhythmic outcomes: Data from the WEARIT-II prospective registry.
    Goldenberg I, Younis A, McNitt S, Klein H, Goldenberg I, Kutyifa V.
    J Cardiovasc Electrophysiol; 2024 Apr 24; 35(4):785-793. PubMed ID: 38383981
    [Abstract] [Full Text] [Related]

  • 18. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D, König T, Hohmann S, Bauersachs J, Veltmann C.
    J Am Heart Assoc; 2017 Jan 17; 6(1):. PubMed ID: 28096098
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the Outcome of Patients Protected by the Wearable Cardioverter Defibrillator (WCD) for <90 Wear Days versus ≥90 Wear Days.
    Dreher TC, El-Battrawy I, RÖger S, Rosenkaimer SL, Gerhards S, Kuschyk J, Borggrefe M, Akin I.
    In Vivo; 2020 Jan 17; 34(6):3601-3610. PubMed ID: 33144474
    [Abstract] [Full Text] [Related]

  • 20. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital.
    Sinha AM, Bense J, Hohenforst-Schmidt W.
    J Interv Card Electrophysiol; 2021 Nov 17; 62(2):401-407. PubMed ID: 33200285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.